A similar mechanism involving an IL-7Rα homodimer could serve as an explanation of the signaling effects that the gain-of-function mutations in T-ALL and B-ALL patients have independent of γc and IL-7 presence (46, 53). The gene discussed is IL7R; the disease is acute lymphoblastic leukemia.